













Introduction. Trochanteric fractures are frequent and
generally associated with bone fragility. There is still de-
bate on the best fixation device to treat stable or rather
stable trochanteric fractures: we report our clinical and
radiological results of fixation with Proximal Femoral
Nail “antirotation” (PFNa) in a population of patients
compared to a control group treated by Sliding Hip
Screw (SHS). 
Materials and methods. A prospective study was con-
ducted in 71 consecutive patients treated by PFNa
(group A), and 69 by a SHS (group B), with a mean age
of 81.6 and 83.4 years respectively. Short Form 12 was
administered to check postoperative results, and the fol-
lowing parameters were evaluated: range of motion,
evaluation of pain, gait ability, X-rays, and Tip Apex Dis-
tance Index.
Results. A minimum follow-up was conducted in 128 pa-
tients: 66 subjects belonging to the PFNa group and 62
to the DHS group. All patients in the group A were able
to reach partial or full weight-bearing on the operated
leg before leaving the hospital. Forty-four patients
(63.8%) of the group B were able to walk with partial
weight-bearing before discharge.
We recorded 17 complications with a final overall per-
centage of 17.2% on the overall study population with
one single case of failure in both the two groups.
Discussion. A statistical significance (p<0.01) of superi-
ority for PFNa was demonstrated regarding surgical
time, amplioscope time, intraoperative blood loss, hospi-
tal stay, recovery of weight-bearing before discharge.
Less significant results (p<0.05) were found for walking
ability at the three-months follow-up and patients’ satis-
faction 6 months after surgery.
Conclusions. PFNa may be considered an useful choice
for the treatment of stable or rather stable trochanteric
fractures as well as DHS. The light superiority of PFNa
may be principally related to its mechanical advantages.
KEY WORDS: trochanteric fractures; femur; fragility fractures; intramedullary
nail; sliding hip screw; fixation; PFNa; DHS; cut-out.
Introduction
Trochanteric fractures are generally associated with bone
fragility and caused by a low energy trauma: a significative
increase of these fractures is expected on the next decades
(1, 2). Improvements of anaesthesiologic and surgical tech-
niques have increased the rate of success and reduced the
elevated risk of death within the first year after fracture, inde-
pendently from the patients’ age and health status [2). Surgi-
cal fixation and early rehabilitation are the goals of an ade-
quate treatment in order to allow a quick recovery for pa-
tients. The recent acquisition that an early timing (<48 hours
from trauma) of surgical treatment may reduce postoperative
complications and mortality adds to our knowledge further
implications (3, 4).
The Sliding Hip Screw (SHS) is considered the gold standard
device for fixation of stable trochanteric fractures (5-15). In
case of unstable or reverse obliquity pattern fracture, in-
tramedullary nails seem to be more effective with respect to
SHS (16-18). However, the first intramedullary nails showed
high rates of intraoperative complications (5, 12, 14, 15, 19-
25). Modern nails are free from such drawbacks and easier
to be applied. Among these, the Proximal Femoral Nail “an-
tirotation” (PFNa®, Synthes, Oberdorf, Switzerland) has been
recently released, showing in vitro biomechanical improve-
ments (26). To date, few papers in literature have reported
the clinical results of PFNa in the treatment of trochanteric
fractures (27-31).
The aim of this paper is the evaluation of our clinical and ra-
diological results of fixation of stable or minimal unstable
trochanteric fractures with PFNa in a population of patients
compared to a control group treated by SHS. 
Materials and methods
A prospective study was performed on 140 consecutive pa-
tients affected by a trochanteric fracture, treated by internal
fixation either with PFNa or DHS® (Synthes, Oberdorf,
Switzerland) between January 2007 to December 2009 at
the Authors’ Institution. Inclusion criteria were adult patients
with trochanteric fracture (31.A1 or 31.A2 according to AO
classification) (32), able to give a full consent to the study.
Exclusion criteria were: patients with a 31.A3 fracture, psy-
chiatric diseases, any form of neurologic deficit to lower
limbs, any contraindication to surgery. Patients were ran-
domized for treatment with PFNa or DHS with a sealed en-
velopes system after adequate information. The local Institu-
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tional Review Board approved the study, and all patients
gave their informed consent to the procedure, acquisition of
clinical informations, and radiologic follow-up.
Two groups resulted: the group A (PFNa) of 71 patients and
the group B (DHS) of 69 patients. In the group A, there were
29 male and 42 female patients, with a mean age of 81.6
years (range: 67-98). In the group B, 25 subjects were male
and 44 females with a mean age of 83.4 years (range: 64-
98). Demographic data of the enrolled patients are presented
in Table 1.
All subjects were studied by conventional radiology in Emer-
gency Room, received antibiotic and antithromboembolic
prophylaxis, and were evaluated with a subjective health sur-
vey concerning the status until the day of the fracture, the
Short Form 12 (SF12) (33). In the group A, almost all pa-
tients presented a single fracture, following an accidental
fall, and only 12 (16.9%) were affected by other fractures
(wrist, chest, proximal humerus), additional minor lesions as
head, spine, or legs bruises or sprains. Thirty-eight patients
lived by their own and without any support for daily activities;
some of them lived with other relatives, needing some help
in daily life actions; the remainders were assisted in residen-
tial healthcare facilities. In 55 cases (77.5%), patients were
affected by comorbilities, mostly related to cardiologic, meta-
bolic, and circulatory issues. The group A consisted in 21
closed fractures classified as 31.A1 (35.2%), 45 (64.7%) as
31.A2.
In the group B, all patients but fifteen (21.7%) presented a
single fracture: associated lesions consisted in dorsal or lum-
bar spine, wrist, or shoulder fractures, and bruises, sprains,
wounds. Comorbilities were reported in 54 cases (78.3%).
The group B consisted in 28 fractures type 31.A1 (40.6%),
41 type 31.A2 (59.4%). All were closed fractures.
All patients (group A + B) underwent a surgical procedure
under fluoroscopy, within an average time of 2.3 days after
hospitalization (range: 1-7 days). About 80.4% of fractures
were treated in the first 48 hours after trauma (early timing).
Intraoperative data concerning blood loss, operative and ra-
diological exposure time, and postsurgical onset of complica-
tions were registered. A protocol of functional recovery was
proposed with assisted passive motion in bed at the first
postoperative day. At second postoperative day, depending
on pain tolerance, patients were allowed to seat in bed per-
forming active knee and ankle exercises. From the third
postoperative day in stable patterns, assisted standing and
gait exercises with devices were proposed. The same exer-
cises were later allowed in patients with poor bone quality
(as tested during surgery), or with associated spine or arm
fractures. Subjects were then discharged, and sent to reha-
bilitative facilities in a way to complete their functional recov-
ery.
PFNa system presents a proximal angulation of 6° on the
coronal plane, and no bendings on the sagittal one, in order
to be implanted bilaterally. It is available in several sizes
(length: from 170 mm to 420 mm, with 40 mm increments),
and with different angles between helicoidal blade and body
of the nail (125°, 130°, 135°). Finally, the helicoidal blade
lengthens from 80 mm to 125 mm, with 5 mm increments.
The helicoidal blade is introduced “open” after reaming a
bone tunnel (in younger patients) or directly in porotic bone,
approximately 10 mm from the surface of the femoral head:
then, it is closed by a locking mechanism in the body of the
nail with an inner screwing system, with an effect similar to
set screws of other intramedullary devices.
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DHS system presents well-known features, and the surgical
technique has been reported since many years in literature.
Follow-up evaluations consisted in outpatient visits at one,
three, six, and twelve months: SF12 was administered to
check postoperative results. Criteria to assess clinical out-
comes were based on the evaluation of pain, range of mo-
tion (ROM), and gait ability. Standard X-rays were made to
evaluate blade positioning on femoral neck and head follow-
ing Kyle’s classical criteria (34), and Tip-Apex Distance
(TAD) (35), both considered the more predictive parameters
for the assessment of potential mechanical failures of fixa-
tion. As reported in recent papers (36, 37), TAD index was
calculated on fractures treated both with extramedullary and
intramedullary fixation devices (Figure 1). Radiographs were
also used for evaluation of bone healing and periarticular os-
sifications. The full healing of fractures was assessed by
check of fragments alignment, recovery of posteromedial
buttress, and femoral neck length on standard X-rays. From
a clinical point of view, the healing was confirmed when pa-
tients were able to standing free with full weight bearing, and
to walk independently, with or without assisting devices.
A statistical analysis was performed by SPSS 17.0 software
(SPSS Inc., Chicago, IL, USA) using the Student’s t-test and
the X2 test for categorical variables with a significance level
of p<0.05.
Results
The groups were substantially homogeneous. Two patients
in the group A and four in the group B died before complet-
ing the one-year follow-up. One patient in both groups did
not presented at our outpatients’ clinic after the 3-months
evaluation. Other two patients in the group A and two in the
group B did not attend the last follow-up visit. Thus, a com-
plete one-year follow-up was conducted in 128 patients, 66
subjects belonging to the PFNa group and 62 to the DHS
group. 
In the group A, fracture fixation was achieved by a 130° PF-
Na nail in 62 patients (87.3%), while the others were treated
by a 125° nail. In 64 patients (90.1%), a 10 mm diameter PF-
Na was implanted; in the others, a 11 mm diameter was cho-
sen. All nails were 200 mm long, distally and statically fixed. 
In the group B, 40 patients (58.0%) were treated by a 4-holes
135° DHS, 17 (24.6%) by a 4-holes 140° DHS, 3 (4.4%) by a
4-holes 145° DHS, 2 (3.0%) by a 6-holes 135° DHS.
In the PFNa group, the mean surgical time was 46.1 minutes
(range: 30-85); the mean amplioscope time was 60.4 sec-
onds (range: 45-85). The average blood loss was about
129.6 cc (range: 40-280). In the DHS group, the mean surgi-
cal time was 63.4 minutes (range: 40-105); the mean amplio-
scope time was 45.8 seconds (range: 35-65). The average
blood loss was about 250.2 cc (range: 120-500). All patients
received two bags of heterologous blood postoperatively;
one patient in the group A and two in the group B needed a
pre-surgical blood transfusion. 
Postoperative X-rays in the group A demonstrated anatomical
reduction in all cases but 3 (4.5%) in which a varus deformity
more than 5° was present. In the group B, we recorded an
anatomical reduction in all cases but 2 (3.0%) with a valgus
deformity less than 5° and of varus deformity less than 4°.
Mean TAD resulted in 25 mm (range: 12-35) in group A,
24mm (range: 13-34) in the group B. Referring to its position,
the spiral blade was implanted on inferior and middle portion
of the femoral neck in 35 cases; on inferior and anterior in 16
cases; on middle in 8 cases; on inferior and posterior in 3
cases; on middle and anterior in 3 cases; on superior and an-
terior in 1 case. According to the same criteria, the cephalic
screw on the DHS group was positioned on inferior and mid-
dle portion of the femoral neck in 39 cases; on inferior and
anterior in 16 cases; on middle in 4 cases; on inferior and
posterior in 2 cases; on middle and anterior in 1 case.
All patients were able to reach an assisted gait with a frame,
and partial or full weight-bearing on the operated leg before
leaving the hospital in the group treated by PFNa. Forty-four
patients (63.8%) treated by DHS were able to walk with par-
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Figure 1 - Example of TAD evaluation: TAD is
22 mm.
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tial weight-bearing before discharge: the remainders were not
able to apply weight-bearing on the operated leg (10 subjects
with 31.A2 fractures), or were not allowed to for an associat-
ed spinal fracture or other concomitant clinical issues (3 pa-
tients  with 31.A2 fractures, 1 with 31.A1 fracture).
We recorded 17 complications, with a final overall percentage
of 17.2% on the overall study population. In the group A, we
had 4 complications (6.1%) not correlated with the device:
death (one case, 9 days after surgery related to pulmonary
embolism), pulmonary infection (one case, treated by antibi-
otic administration), not complicated Deep Venous Thrombo-
sis (DVT - 2 cases, managed with Low Molecular Weight He-
parin and mechanical compressive devices). In 4 cases
(6.1%), we had complications related to the procedure: a sin-
gle case of implant failure at one month that required surgery;
two cases of Spiral Blade medial migration through the
femoral head without protrusion over the cortex; one case of
slight lateral protrusion of the blade, with trochanteric bursitis
treated with local steroid injections after fracture healing. The
single failure occurred one month after surgery in a 81-year-
old patient who complained pain and unable to walk. X-rays
demonstrated a cut-out of the nail. The implant was removed
and the patient underwent a cemented hip hemiarthroplasty.
After two months the patient was able to walk without crutch-
es and without symptoms (Figure 2).
In the group B, we recorded 9 complications (13.3%): one
death (on third post-operative day due to cardiac failure);
one ab ingestis pulmonary infection (treated by Intensive
Care Management); two DVTs (managed as previously stat-
ed); one urinary tract infection (treated by systemic antibi-
otics); two superficial wound infections (treated by wound
advanced care and antibiotics); we also had a case of im-
plant failure requiring surgery at three months of follow-up;
one case of migration of two of the 6 screws of a DHS plate
without any complaint by the patient. The single failure oc-
curred in a 80-year-old patient who complain symptoms and
severe functional impairment related to an instability of the
device with breakage of some screws and varus deformity.
As for the failure of group A, the patient underwent a hard-
ware removal and a cemented hemiarthroplasty with success
(Figure 3). Mortality and complications data of the two
groups are presented in Table 2.
At the 3-month follow-up visit, in the group A 58 patients
(81.7%) were able to walk independently without crutches or
at least with one cane; the remainders (all with 31.A2 frac-
tures) were able to perform an almost normal gait within 6
months post-operatively. At the same interval, in the group B
45 patients (67.2%) were able to walk independently without
crutches or at least with one cane: all the others (31.A2 frac-
tures) reached the same result at 6 months post-operatively,
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Figure 2 - Preoperative images of a 81-year-old patient with a 31.A2 trochanteric fracture (a) treated by PFNa (b). One month after surgery the pa-
tient complained pain and was unable to walk: radiologic evidence of cut-out (c). 
Figure 3 - Preoperative X-rays of a 80-year-old patient with a 31.A2 trochanteric fracture treated by DHS (a). Three months after surgery: screws break-
age and varus deformity (b).
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with 7 patients (10.1%) recommended to use permanently at
least one cane.
In the PFNa series, we recorded radiographic findings of
complete fracture healing at 6-months in 59 patients
(86.7%). At the same time, in the other 5 cases (7.2%), radi-
ograms showed incomplete healing, even if clinically the pa-
tients were able to walk without a significant impairment, and
with a painless ROM. At the same time, in the remainders
(6.0%) we found a persistency of pain and a limited ROM
correlated with an incomplete radiographic healing, and
some functional limitation (all were 31.A2 fractures).
In the control series, we observed radiographic a complete
fracture healing at 6-months in 53 patients (84.1%); in 6 pa-
tients (9.5%), radiographs showed incomplete healing with-
out significative symptoms, and with almost full ROM. In the
remainders (6.3%) persistency of pain and limited ROM cor-
related with incomplete radiographic healing at 6-months fol-
low-up, corresponding in all cases to 31.A2 fractures.
Forty-nine patients (74.2%) treated by PFNa referred a re-
stored walking ability and a feeling of health very close to the
status before the fracture, reaching a mean value of 59.4
(range: 46-66) for the physical component, and 66.0 (range:
55-74) for the mental component of SF12 one year after
surgery. Forty-one patients (66.1%) treated by DHS referred
a full recovery and health status as before the fracture,
reaching a mean value of physical component of 58.3
(range: 43-66), and mental of 64.7 (range: 55-72). Intra and
post-operative data of the enrolled patients are presented in
Table 3.
Finally, in 7 patients (10.6%) of group A and in 3 patients
(4.8%) of group B we found periarticular ossifications after
the first follow-up visit, treated with oral administration of dai-
ly 75 mgs of Indometacin for 4 weeks when appropriated.
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Table 2  Mortality, dropouts, and complications. 
 PFNa DHS Statistical 
significance 
Dead at follow up 1 year 
Lost at follow up 3 months  





Deep Venous Thrombosis 
Urinary tract infection 
Superficial wound infection 
Mechanical complications  
   - Spiral Blade migration 
   - Lateral blade protrusion  
   - Migration of plate screws 














































PFNa: proximal femoral nail antirotation. DHS: dynamic hip screw. 
Data  are mean ± SD (range) for age or n. Quantitative variables 
were analyzed using the Student’s t-test and categorical variables 




















Table 3  Intra and postoperative data. 
 
 PFNa DHS Statistical 
significance 
Surgical time (minutes) 46.06 ± 10.10 61.21 ± 15.01 p < 0.01 
Amplioscopic time 60.45 ± 16.52 45.89 ± 8.17 p < 0.01 
Estimated intraoperative blood loss (cc) 127.80 ± 54.52 250.16 ± 89.54 p < 0.01 
Postoperative blood bags (n) 2.10 ± 0.43 2.06 ± 0.36 NS 
Hospital Stay (days) 
 
Walking  with partial or full weight-bearing before discharge  
 
Independent walking ability at 3 months (n) 
 
Radiologic healing at 6 months (n) 
 
Patients’satisfaction at 6 months (n) 
 
SF12 mean value at 12 months 
•! physical  
•! mental  
 
Restore walking activity and health status pre-fracture at 12 
months (n) 






 59/68 (86.76%) 
 48/68 (70.58%) 
 
 59.7 ± 10.04 










 53/63 (84.12%) 
 33/63 (52.38%) 
 
 58.4 ± 9.78 




p < 0.01 
 
p < 0.01 
 
 p < 0.05
 
 NS 







PFNa: proximal femoral nail antirotation. DHS: dynamic hip screw. Data are mean ± SD (range) or n; Quantitative variables were analyzed 
using the Student’s t-test and categorical variables were analyzed by the X2 test. NS not statistically significant (p>0.05).   
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Discussion
The surgical treatment of trochanteric fractures is intended to
prevent morbility and mortality, improving life quality, and
limiting complications with a reduction of personal and social
costs (2, 5-8). Even if still debated, an adequate choice of
the fixation device may play a fundamental role. Surgery
means an anatomical reduction, but also a stable fixation.
The stability of a fracture depends on several factors: bone
quality, fracture pattern, reduction, type of fixation device,
surgical technique (38-40). The latter three factors are under
surgeon’s control, despite bone quality and type of fracture.
However, the quality of reduction is also influenced by geom-
etry of fragments, as positioning of fixation device is correlat-
ed with the device itself and pattern of fracture. Thus, the
main variable actually related to surgeons is the choice of
the fixation device. Many Authors consider SHS as the better
choice even if this device has some biomechanical limita-
tions. Its characteristic long lever arm may not allow early
weight-bearing in unstable or reverse pattern fractures: in
these cases, if prematurely allowed, the forces may typically
bear on fracture site influencing negatively the healing
process with concentration of excessive tensile thrusts. On
the other hand, this may be limited increasing the number of
holes and screws: such solution may not however ensure a
stability in severe porotic bone. Finally, a high incidence of
cut-out of SHS cephalic screw is reported in trochanteric
fractures with inverse fracture pattern (21, 41). Recent data
report about cases of excessive sliding of cephalic screw on
the plate, causing groin pain, medial shift of distal fragment,
and leg shortening: all these conditions may lead to high
rates of fixation failure (12, 13, 41-43). However, as before
mentioned, large series of patients with stable or rather sta-
ble (displaced reduced or not properly reduced) trochanteric
fractures treated by SHS device showed excellent results
(44). In the present experience, we had only one mechanical
failure requiring surgery.
The PFNa was introduced to avoid the limits of extrame -
dullary devices (19, 22, 23). Theoretical advantages were
represented by the high biomechanical efficiency in unstable
fractures, the low soft tissues and vascular supply damages,
and the intrinsic mechanical solidity and load distribution with
respect to SHS. The latter feature allows nails to support
most of the forces acting on the hip during gait (axial weight-
bearing and bending moments) avoiding stress on the frac-
ture site (24, 45). There have been many changes and im-
provements, mostly to avoid mechanical complications often
reported (iatrogenic fractures during nail positioning, poor ro-
tation control of cephalic fragment). Recently, a brand new
design of cephalic screw with a helical profile has been intro-
duced as PFNa. Preclinical in vitro tests have shown high
stability and elevated integration due to improved contact
area with the host bone with respect to the previous men-
tioned devices (26). However, interesting studies have com-
pared clinical and radiological results of fractures treated by
SHS and intramedullary nails, with demonstration of efficacy
for both systems at 6-month follow-up (7-9, 14, 25). The un-
stable fractures are usually challenging, and several reports
confirmed the superiority of nails over plates in fixation and
stability (21, 22, 24, 30). Referring to the PFNa system is re-
ported less blood loss and shorter duration of hospitalization
(31, 46) and also a lower biomechanical-inflammatory profile
that can be related to a lower invasiveness of the procedure
(47). Other Authors reported good results also with the SHS
(5, 6, 15, 25) with the same risk of postoperative complica-
tions of PFNa (48). The lack of structural bone on posterior
and medial area of the proximal femoral metaphysis in 31.A2
type fractures and in the lateral cortex on type 31.A3 may
theoretically cause instability with varus or rotational defor-
mity and consequent pending cut-outs. Many studies report
a lower incidence of complications for PFNa (46, 49, 50). Ac-
cording to these studies, we recorded a single mechanical
failure of such nail requiring surgery. Some Authors has fo-
cused the attention on the importance of the femoral head
rotation as a possible cause of cut-out (51, 52). The intro-
duction of a helicoidal blade enhancing the contact area with
bone and compression, ensures an additional antirotative ef-
fect (26, 50). Other studies reported about few cases of
symptomatic perforation of the femoral head by the spiral
blade without gross functional limitations (53, 54). 
In our series, outcomes at one year after surgery, need for
blood transfusions, and radiographic results were similar in
the two groups. We observed significant differences in para-
meters such as intraoperative blood loss, surgical and am-
plioscope times, hospital stay, recovery of weight-bearing
before discharge in the PFNa group with respect to control
(p<0.01). Finally, less significant results (p<0.05) were the
walking ability at the three-months follow-up and the satis-
faction referred by patients 6 months after surgery.
The overall complications rate on this series should be con-
sidered in line with the recent metanalysis (44, 55). 
This study has several limits. The number of patients is not
consistent; no specific study on bone density and bone me-
tabolism was carried out, and the patients with neurologic or
mental impairments were excluded. All these aspects surely
influenced the final outcome, and particularly the selection of
patients without mental conditions given the high rates of
mental degenerative diseases generally affecting patients
with a trochanteric fracture. However, no differences in com-
plications rates between the two groups were recorded. On
the basis of the present study, we support the effectiveness
of intramedullary nailing as well as extramedullary device in
the treatment of trochanteric fractures, allowing satisfactory
results in stable or rather stable fractures. The light superior-
ity of PFNa may be principally related to its mechanical ad-
vantages over sliding hip screw.
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